Dabrafenib 50mg, 75mg Capsules — BRAF V600 Kinase Inhibitor for BRAF V600-Mutated Metastatic Melanoma, NSCLC, Anaplastic Thyroid Cancer and Other BRAF V600E-Mutated Solid Tumours — Used in Combination With Meqsel (Trametinib)
Sacituzumab Govitecan 180mg Injection — TROP-2 Targeted Antibody-Drug Conjugate for Triple-Negative Breast Cancer and HR-Positive HER2-Negative Breast Cancer